Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 307

1.

The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.

Leitinger N.

Subcell Biochem. 2008;49:325-50. doi: 10.1007/978-1-4020-8830-8_12. Review.

PMID:
18751917
[PubMed - indexed for MEDLINE]
2.

Oxidized phospholipids as triggers of inflammation in atherosclerosis.

Leitinger N.

Mol Nutr Food Res. 2005 Nov;49(11):1063-71. Review.

PMID:
16270279
[PubMed - indexed for MEDLINE]
3.

Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.

Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F, Witztum JL.

J Am Coll Cardiol. 2006 Jun 6;47(11):2219-28. Epub 2006 May 15.

PMID:
16750687
[PubMed - indexed for MEDLINE]
Free Article
4.

Inflammatory profile of oxidized phospholipids.

Bochkov VN.

Thromb Haemost. 2007 Mar;97(3):348-54. Review.

PMID:
17334500
[PubMed - indexed for MEDLINE]
5.

Oxidized phospholipids as modulators of inflammation in atherosclerosis.

Leitinger N.

Curr Opin Lipidol. 2003 Oct;14(5):421-30. Review.

PMID:
14501580
[PubMed - indexed for MEDLINE]
6.

Anti-inflammatory properties of lipid oxidation products.

Bochkov VN, Leitinger N.

J Mol Med (Berl). 2003 Oct;81(10):613-26. Epub 2003 Sep 6. Review.

PMID:
13679995
[PubMed - indexed for MEDLINE]
7.

Oxidized phospholipids in control of inflammation and endothelial barrier.

Fu P, Birukov KG.

Transl Res. 2009 Apr;153(4):166-76. doi: 10.1016/j.trsl.2008.12.005. Epub 2009 Jan 21. Review.

PMID:
19304275
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Atherosclerosis in patients with autoimmune disorders.

Frostegård J.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1776-85. Epub 2005 Jun 23. Review.

PMID:
15976324
[PubMed - indexed for MEDLINE]
Free Article
9.

Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis.

Vejux A, Lizard G.

Mol Aspects Med. 2009 Jun;30(3):153-70. doi: 10.1016/j.mam.2009.02.006. Epub 2009 Feb 25. Review.

PMID:
19248805
[PubMed - indexed for MEDLINE]
10.

Infections and autoimmune diseases.

Bach JF.

J Autoimmun. 2005;25 Suppl:74-80. Epub 2005 Nov 8. Review.

PMID:
16278064
[PubMed - indexed for MEDLINE]
11.

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.

Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S; MIRACL Study Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2186-96. doi: 10.1016/j.jacc.2009.02.041.

PMID:
19497447
[PubMed - indexed for MEDLINE]
Free Article
12.

Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.

Minerva Cardioangiol. 2007 Dec;55(6):821-37. Review.

PMID:
18091649
[PubMed - indexed for MEDLINE]
13.

Inflammatory lipids as a target for therapy in the rheumatic diseases.

McMahon M, Brahn E.

Expert Opin Investig Drugs. 2008 Aug;17(8):1213-24. doi: 10.1517/13543784.17.8.1213 . Review.

PMID:
18616417
[PubMed - indexed for MEDLINE]
14.

Modified phospholipids as anti-inflammatory compounds.

Feige E, Mendel I, George J, Yacov N, Harats D.

Curr Opin Lipidol. 2010 Dec;21(6):525-9. doi: 10.1097/MOL.0b013e32833f2fcb. Review.

PMID:
20827191
[PubMed - indexed for MEDLINE]
15.

Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Zinger H, Sherer Y, Shoenfeld Y.

Clin Rev Allergy Immunol. 2009 Aug;37(1):20-8. doi: 10.1007/s12016-008-8094-x. Review.

PMID:
18991025
[PubMed - indexed for MEDLINE]
16.

Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.

Abou-Raya A, Abou-Raya S.

Autoimmun Rev. 2006 May;5(5):331-7. Epub 2006 Feb 3. Review.

PMID:
16782558
[PubMed - indexed for MEDLINE]
17.

Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of antI-DNA response.

Toyoda K, Nagae R, Akagawa M, Ishino K, Shibata T, Ito S, Shibata N, Yamamoto T, Kobayashi M, Takasaki Y, Matsuda T, Uchida K.

J Biol Chem. 2007 Aug 31;282(35):25769-78. Epub 2007 Jun 22.

PMID:
17588942
[PubMed - indexed for MEDLINE]
Free Article
18.

Oxidatively modified autoantigens in autoimmune diseases.

Kurien BT, Hensley K, Bachmann M, Scofield RH.

Free Radic Biol Med. 2006 Aug 15;41(4):549-56. Epub 2006 May 23. Review.

PMID:
16863987
[PubMed - indexed for MEDLINE]
19.

Endothelial dysfunction in rheumatic autoimmune diseases.

Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F.

Atherosclerosis. 2012 Oct;224(2):309-17. doi: 10.1016/j.atherosclerosis.2012.05.013. Epub 2012 May 18. Review.

PMID:
22673743
[PubMed - indexed for MEDLINE]
20.

Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships.

Furnkranz A, Leitinger N.

Curr Pharm Des. 2004;10(8):915-21. Review.

PMID:
15032694
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk